期刊文献+

HPLC法测定复方芩苍鼻喷雾剂中黄芩苷的含量 被引量:4

Content Determination of Baicalin in Compound Qincang Nasal Sprays by HPLC
原文传递
导出
摘要 目的:建立测定复方芩苍鼻喷雾剂中黄芩苷含量的方法。方法:采用高效液相色谱法。色谱柱为Waters Symmetry C18(150mm×4.6mm,5μm),流动相为甲醇-水-磷酸(47:53:0.2,V/V/V),流速为1.0ml/min,检测波长为280nm,柱温为20℃。结果:黄芩苷的质量浓度在6.2~310.0μg/ml范围内与峰面积积分值呈良好线性关系(r=0.9993);平均加样回收率为98.72%,RSD=0.89%(n=9)。结论:本方法简便、快速、准确、重复性好,可用于复方芩苍鼻喷雾剂中黄芩苷的含量测定。 OBJECTIVE: To establish a method for the content determination of baicalin in Compound qincang nasal sprays. METHODS: HPLC method was adopted. The determination was performed on Waters Symmetry C18 (150 mm×4.6 mm, 5 μm) col- umn with mobile phase consisted of methanol-water-phosphoric acid (47 : 53 : 0.2, V/V/V) at the flow rate of 1.0 ml/min. The detec- tion wavelength was set at 280 nm and column temperature was 20 ℃. RESULTS: The linear range of baicalin was 6.2-310.0 μg/ml (r=0.999 3) with an average recovery of 98.72% (RSD=0.89%, n=9). CONCLUSION: The method is simple, rapid, accurate and reproducible, and it is suitable for the content determination of baicalin in Compound qincang biyan sprays.
出处 《中国药房》 CAS CSCD 2013年第7期644-646,共3页 China Pharmacy
关键词 复方芩苍鼻喷雾剂 高效液相色谱法 黄芩苷 含量测定 Compound qincang nasal sprays HPLC Baicalin Content determination
  • 相关文献

参考文献4

二级参考文献25

  • 1刘太明,蒋学华.HPLC同时测定肠循环液中黄芩苷、黄芩素和酚红的浓度[J].华西药学杂志,2005,20(5):390-392. 被引量:12
  • 2严劲松,黄朝建,高申蓉,王秀兰.高效液相色谱法测定肺炎Ⅰ号合剂中黄芩苷的含量[J].中国药房,2006,17(3):214-215. 被引量:11
  • 3张福维,林春,关崇新.黄芩甙提取工艺研究[J].天然产物研究与开发,2006,18(2):295-297. 被引量:8
  • 4林嘉民,陈娴瑛,花仲卉.宫宁颗粒质量标准研究[J].中国药房,2006,17(20):1582-1583. 被引量:4
  • 5[1]Bachert C.Persistent rhinitis-allergic or nonallergic? Allergy,2004,59 Suppl 76:11-15.
  • 6[2]Hamilos DL,Lanza DC,Kennedy DW.Rhinosinusitis and the revised "sinusitis practice parameters".J Allergy Clin Immunol,2005,116:1267-1268.
  • 7[3]Borish L.Maybe rhinitis,maybe sinusitis,maybe rhinitis and sinusitis,but certainly not rhinosinusitis! J Allergy Clin Immunol,2005,116:1269-1271.
  • 8[4]Johansson SG,Hourihane JO,Bousquet J,et al.Arevised nomenclature for allergy.An EAACI position statement from the EAACI nomenclature taskforce.Allergy,2001,56:813-824.
  • 9[5]Meltzer EO,Hamilos DL,Hadley JA,et al.Rhinosinusitis:establishing definitions for clinical research and patient care.J Allergy Clin Immunol,2004,114(6 Suppl):155-212.
  • 10[6]Fokkens W,Lund V,Bachert C,et al.EAACI position paper on rhinosinusitis and nasal polyps executive summary.Allergy,2005,60:583-601.

共引文献32

同被引文献26

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部